Publications
5808 Results
- Journal / Conference
- Breast Cancer Research and Treatment 171 (2):325-334
- Year
- 2018
- Research Committee(s)
- Breast
- PMID
- PMID29789969
- PMC
- PMC6076849
- Study Number(s)
- CTSU/C40503
Identification of Risk Factors for Toxicity in Patients With Hormone Receptor-Positive Advanced Breast Cancer Treated With Bevacizumab Plus Letrozole: A CALGB 40503 (Alliance) Correlative Study
- Journal / Conference
- Journal of Cancer Survivorship:Research and Practice, 2017 Feb;11(1):32-40; 2016 Jul 12 [Epub ahead of print]
- Year
- 2017
- Research Committee(s)
- Lymphoma
- PMID
- PMID27405732
- PMC
- PMC5233644
- Study Number(s)
- SWOG-9133, SWOG-9208
Seven year follow-up for energy/vitality outcomes in early stage hodgkin's disease patients treated with subtotal lymphoid irradiation versus chemotherapy plus radiation: SWOG S9133 and its QOL companion study, S9208
- Journal / Conference
- Biology of Blood and Marrow Transplantation Apr;23(4):691-696; Epub 2017 Jan 3.
- Year
- 2017
- Research Committee(s)
- Leukemia
- PMID
- PMID28062215
- PMC
- PMC5465962
- Study Number(s)
- S0333
Next-generation sequencing in adult B cell acute lymphoblastic leukemia patients
- Journal / Conference
- Cancer Jul 1;123(13):2444-2451. Epub 2017 May 2.
- Year
- 2017
- Research Committee(s)
- Breast
- PMID
- PMID28464211
Osteoporosis therapy prolongs event-free survival in post-menopausal breast cancer patients randomized to adjuvant exemestane or anastrozole: NCIC CTG MA.27
- Journal / Conference
- Cancer Epidemiology Biomarkers & Prevention 2017 Jan;26(1):21-29; 2016 Dec 16. [Epub ahead of print]
- Year
- 2017
- Research Committee(s)
- Breast, Gastrointestinal, Genitourinary, Gynecologic, Leukemia, Lung, Lymphoma, and Sarcoma
- PMID
- PMID27986655
- PMC
- PMC5370550
- Study Number(s)
- S0033, S0221, SWOG-8507, SWOG-8516 (INT-0067), SWOG-8600, SWOG-8706, SWOG-8736 (INT-0093), SWOG-8795 (INT-0094) (EST-1888), SWOG-8814, SWOG-8897, SWOG-8949, SWOG-9012, SWOG-9031, SWOG-9333, SWOG-9346, SWOG-9420, SWOG-9500, SWOG-9509, S9701, S9916
Association between body mass index and cancer survival in a pooled analysis of 22 clinical trials
- Journal / Conference
- Cancer Jul 1;123(13):2472-2481; 2017 Feb 21[Epub ahead of print]
- Year
- 2017
- Research Committee(s)
- Leukemia
- PMID
- PMID28222251; PMC5705230
- Study Number(s)
- S0106, S0112, SWOG-8600, SWOG-9031, SWOG-9333, SWOG-9500, S9918
Prognostic methylation markers for survival in cytogenetically normal AML patients treated on SWOG trials
- Journal / Conference
- Cancer Epidemiology Biomarkers & Prevention Aug;26(8):1276-1287; Apr 26 [Epub ahead of print]
- Year
- 2017
- Research Committee(s)
- Cancer Control, Prevention, Screening, and and Surveillance
- PMID
- PMID28446545
- PMC
- PMC5540798
- Study Number(s)
- SWOG-9217
A pooled analysis of 15 prospective cohort studies on the association between fruit, vegetable, and mature bean consumption and risk of prostate cancer
- Journal / Conference
- Journal of Clinical Oncology Aug 20;35(24):2745-2753; 2017 May 9 [Epub ahead of print]
- Year
- 2017
- Research Committee(s)
- Leukemia
- PMID
- PMID28486043; PMC5562170
- Study Number(s)
- S1117
A randomized phase II study of azacitidine alone or in combination with lenalidomide or with vorinostat vs. azacitidine monotherapy in higher-risk myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML): North American Intergroup Study SWOG S1117
- Journal / Conference
- JAMA Oncology Apr 1;3(4):516-522; 2016 Dec 15 [Epub ahead of print]
- Year
- 2017
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID27978579
- PMC
- PMC5665683
- Study Number(s)
- S1115
Effect of Selumetinib and MK-2206 vs Oxaliplatin and Fluorouracil in Patients With Metastatic Pancreatic Cancer After Prior Therapy: SWOG S1115 Study Randomized Clinical Trial
- Journal / Conference
- Lancet Feb 4;389(10068):519-527. Epub 2016 Dec 23.
- Year
- 2017
- Research Committee(s)
- Myeloma
- PMID
- PMID28017406
- PMC
- PMC5546834
- Study Number(s)
- S0777